Carnegie Mellon: A Key Ruling For Biotech Patents
On Sep. 8, 2008, the United States Court of Appeals for the Federal Circuit ruled that certain claims of a patent owned by Carnegie Mellon University were invalid as lacking adequate...To view the full article, register now.
Already a subscriber? Click here to view full article